AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2016

Jul 16, 2016

34983_dirs_2016-07-15_fc41cffc-b64f-4f2a-8fe1-c749189f8401.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-14	Common Shares	P	8800	$0.1	Acquired	7040114	Direct
2016-07-14	Common Shares	P	5000	$0.135	Acquired	7045114	Direct
2016-07-15	Common Shares	P	5000	$0.135	Acquired	7050114	Direct
2016-07-15	Common Shares	P	7400	$0.1195	Acquired	7057514	Direct
2016-07-15	Common Shares	P	5105	$0.1194	Acquired	7062619	Direct
2016-07-15	Common Shares	P	6000	$0.1194	Acquired	7068619	Direct
2016-07-15	Common Shares	P	10000	$0.1195	Acquired	7078619	Direct
2016-07-15	Common Shares	P	7000	$0.11	Acquired	7085619	Direct
2016-07-15	Common Shares	P	8000	$0.13	Acquired	7093619	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4971844	Indirect
Common Shares	7031314	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.1	2019-12-23	Common Shares (550000)	550000	Direct
Stock Options	$0.09	2018-06-18	Common Shares (247500)	797500	Direct
Warrants	$0.23	2017-05-15	Common Shares (187000)	187000	Indirect

Footnotes

F1: Canadian Dollars